Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Pelvic Mass


Basics


Description


  • Pelvic masses may be gynecologic or nongynecologic, solid or cystic.
  • Pathology may occur in the uterus, bowel, urinary bladder, or the adnexal region, which contains the ovary, fallopian tube, round ligament, vessels, lymphatics, and nervous plexus.
  • The etiology of pelvic masses differs between reproductive, postmenopausal, and premenarchal women.

Epidemiology


  • Reproductive age
    • 85% of adnexal masses are benign (3).
    • Up to 6 " “7% of women have asymptomatic adnexal masses.
    • Physiologic and functional ovarian cysts occur as a normal process of ovulation.
    • Polycystic ovarian syndrome seen in about 22% of women.
    • Uterine fibroids are found in at least 20% of women.
    • Benign cystic teratoma (dermoid cyst) is the most common ovarian neoplasm in this group.
  • Postmenopausal
    • Approximately 30 " “60% risk of malignancy
    • 1/3 of cases of ovarian cancer occur over the age of 65 years.
    • Ovarian cancer is the fifth leading cause of cancer death in women.
    • An estimated 21,880 new ovarian cancer cases and 13,850 deaths from ovarian cancer in 2010 (3)
    • Up to 75% of ovarian cancers are diagnosed at a late stage (3).
    • 5-year survival is 94% for local ovarian cancer, 73% for regional spreading cancer, and 28% with distant metastases (1).

Risk Factors


  • Reproductive age
    • Approximately 46% of patients with tubo-ovarian abscess have history of pelvic inflammatory disease (PID).
    • Leiomyoma:
      • 3 " “5 times more common in African American women
      • Overweight
      • Nulliparity
    • Functional cysts arise from normal physiologic variation due to elevated gonadotropin, but there is increased propensity to form individual follicular cysts in cystic fibrosis patients.
  • Postmenopausal
    • Ovarian cancer:
      • Lifetime risk increases 3 times with one first-degree relative with epithelial ovarian cancer.
      • Advancing age is the most important risk factor for malignancy.
      • Nulliparity, late menopause, and higher socioeconomic status are other risk factors.

Pathophysiology


  • Reproductive age
    • Tubo-ovarian abscess is due to undertreated or untreated PID that results in scarring of tubal fimbria leading to polymicrobial pus collection.
    • Follicular cysts are thin-walled, translucent cysts filled with water, clear or straw-colored fluid, situated in the ovarian cortex.
    • Mature cystic teratomas are cystic structures containing elements of all 3 germ-cell layers and may contain bone and teeth.
    • Leiomyoma is a benign tumor composed of smooth muscle cells in concentric whorls.
  • Postmenopausal
    • Ovarian cancer may arise from the surface of the ovary (epithelial type, also the most common), egg-producing cells (germ-cell), or from supportive tissue (stromal type, least common).

Diagnosis


History


Signs and symptoms ‚  
  • Reproductive age
    • Tubo-ovarian abscess typically presents as abdominal/pelvic pain with fever.
    • Functional cysts are frequently asymptomatic, but may cause abdominal pain and pressure if increased size or if cyst ruptures.
    • Mature cystic teratomas are usually asymptomatic unless tumor ruptures or causes torsion, presenting as an acute abdomen.
    • Patients with leiomyomas present with back pain, pelvic pain or pressure, dysmenorrhea, menorrhagia, and history of infertility.
  • Postmenopausal
    • Ovarian cancer symptoms are usually vague, leading to late detection.
    • Symptoms may include pelvic or abdominal pain, increased abdominal size, urinary frequency urgency or incontinence, early satiety, and weight loss.

Physical Exam


  • Pelvic/bimanual exams are important to distinguish size, location, consistency, and mobility of masses.
  • Bladder should be empty during bimanual examination.
  • Reproductive age
    • Tubo-ovarian abscess may present as fever, purulent cervical discharge, and cervical motion tenderness.
    • Functional cysts may be palpated, but may rupture during pelvic exam.
    • Mature cystic teratoma on palpation has both cystic and solid components with doughy consistency; occurs bilaterally 10 " “15% of the time.
    • Patients with leiomyomas present with an enlarged, irregularly shaped uterus, which may be pedunculated arising from the fundus. This condition may be misdiagnosed as an ovarian mass.
  • Postmenopausal
    • Ovarian cancer may be associated with pleural effusion, abdominal distention with ascites, abdominopelvic mass, cul-de-sac nodularity, and groin adenopathy.

Tests


Lab
  • Quantitative serum Ž ²- HCG to rule out Ectopic pregnancy
  • CBC to check for leukocytosis
  • CA-125 (2):
    • Should not be used as a screening test when a mass is not identified
    • Should not be used in the routine work-up of a premenopausal woman
    • Increased levels >35 U/mL should prompt further evaluation.
    • May be elevated in benign conditions like endometriosis, PID, liver and renal disease

Imaging
  • Transvaginal/Transvaginal ultrasound not transabdominal ultrasound (2):
    • Most valuable diagnostic study in the initial evaluation of pelvic mass
    • Differentiates cystic (simple or complex) and solid tumors
    • Presence of ascites is suspicious for malignancy.
  • CT scan:
    • Increased resolution and ability to distinguish subtle differences
  • MRI:
    • Provides detailed evaluation of pelvic anatomy with excellent tissue contrast ability
    • Able to diagnose some benign entities especially endometriosis

Differential Diagnosis


  • Gynecologic
    • Pregnancy
    • PID leading to tubo-ovarian abscess
    • Ectopic pregnancy
    • Polycystic ovarian syndrome
    • Fallopian tube cancer
    • Uterine cancer
    • Functional cyst
    • Benign ovarian cancer
    • Endometriosis
    • Leiomyoma
    • Epithelial carcinoma of the ovary
    • Ovarian sarcoma
    • Ovarian germ-cell tumor
    • Sex cord or stromal tumor
  • Nongynecologic
    • Appendicitis/abscess
    • Diverticulosis
    • Colon cancer
    • Bladder tumor
    • Polycystic kidney disease
    • Retroperitoneal mass
    • Primary adenocarcinoma of the colon with metastasis to the ovary (Krukenberg tumor)

Treatment


Additional Treatment


General Measures
Reproductive age: ‚  
  • If pregnancy test is positive, rule out ectopic pregnancy (2).
  • Refer to gynecology if mass >10 cm, concerning ultrasonographic findings or persistence >12 weeks
  • Tubo-ovarian abscess:
    • Broad-spectrum IV antibiotics
  • Functional cysts:
    • Majority will spontaneously be reabsorbed or ruptured within 4 " “8 weeks of the initial diagnosis.
    • Ultrasonography to establish if cyst is simple or complex
    • There is no evidence that oral contraceptive pills are beneficial in decreasing the size of the cysts (2).
  • Leiomyoma:
    • For symptomatic patients, progesterone (with or without estrogen), danazol, or GnRH agonists may be used.
    • Myomectomy may be done.
    • Hysterectomy if pregnancy is not desired
  • Mature cystic teratoma:
    • Risk of rupture or slow spilling of sebaceous fluid from tumor; may present as an acute abdomen
    • Operative treatment is cystectomy with preservation of normal ovarian tissue if possible.

Postmenopausal age: ‚  
  • Refer to gynecologist if mass >10 cm, concerning ultrasonographic findings, CA-125 level >35 U/mL or persistence >12 weeks (2)
  • Annual rectovaginal evaluation, CA-125 determination, and transvaginal ultrasound are recommended for high-risk patients.
  • Chance of malignancy increases with age (>50 years old) and size of cyst.
  • Simple cyst <10 cm, asymptomatic with normal Pap smears, and CA-125 levels may be observed but with serial follow-up with ultrasonography every 4 " “6 weeks.

Surgery


Laparotomy vs. laparoscopy ‚  
  • Laparoscopy has the accompanying risk of spilling malignant cells into peritoneal cavity by rupture of ovarian capsule during removal of mass.
  • Preoperative criteria for laparoscopy:
    • Age (postmenopausal has increased likelihood of malignancy)
    • Ultrasonographic characteristics including nonadherent smooth and thin-walled cysts, absence of papillae, or internal echoes

Ongoing Care


Complications


  • Reproductive age
    • Tubo-ovarian abscess:
      • Increased likelihood of infertility and ectopic pregnancy
    • Functional cyst:
      • Recurrence after laparoscopy may be 2%.
      • Higher recurrence up to 40% for simple drainage
      • Rupture of corpus luteum cyst may cause slight-to-severe bleeding.
      • Rarely, adnexal torsion may occur in 1% of cases of theca lutein cysts.
    • Mature cystic teratoma:
      • May undergo malignant transformation in 1 " “2%, usually over age 40
      • May be associated with thyrotoxicosis, carcinoid syndrome, and autoimmune hemolytic anemia
      • Rupture of contents in peritoneal cavity is the most serious complication, occurring in 0.7 " “4.6% of the patients.
    • Leiomyoma:
      • Degeneration occurs when there is decreased blood supply, but has a 0.3 " “0.7% chance for malignant degeneration.
      • Approximately 1 in 4 women eventually undergo hysterectomy after myomectomy due to recurrence.
  • Postmenopausal
    • Ovarian cancer:
      • Outcomes are poor with 5-year survival rates for all stages of only 46%.

References


1 Cancer facts & figures 2010. Atlanta, GA: American Cancer Society, 2010.2Givens ‚  V, Mitchell ‚  GE, Harraway-Smith ‚  C. Diagnosis and management of adnexal masses. Am Fam Physician.  2009;80(8):815 " “820. ‚  [View Abstract]3McBee ‚  WCJr, Escobar ‚  PF, Falcone ‚  T. Which ovarian masses need intervention? Cleve Clin J Med.  2007;74(2):149 " “157. ‚  [View Abstract]

Additional Reading


1Droegemueller ‚  W., Stenchever ‚  M Comprehensive gynecology. St. Louis, MO: Mosby, 2001;726 " “727.2Stenchever ‚  M., Stenchever ‚  M Comprehensive gynecology, 4th ed. St. Louis, MO: Mosby, 2001:665 " “713.

Codes


ICD9


  • 256.4 Polycystic ovaries
  • 620.2 Other and unspecified ovarian cyst
  • 789.30 Abdominal or pelvic swelling, mass, or lump, unspecified site
  • 220 Benign neoplasm of ovary
  • 183.0 Malignant neoplasm of ovary

ICD10


  • E28.2 Polycystic ovarian syndrome
  • N83.29 Other ovarian cysts
  • R19.00 Intra-abd and pelvic swelling, mass and lump, unsp site
  • D27.9 Benign neoplasm of unspecified ovary
  • C56.9 Malignant neoplasm of unspecified ovary

SNOMED


  • 74285003 mass of pelvic structure (finding)
  • 79883001 cyst of ovary (disorder)
  • 69878008 polycystic ovaries (disorder)
  • 119424003 mature cystic teratoma of ovary (disorder)
  • 363443007 malignant tumor of ovary (disorder)

Clinical Pearls


  • Pregnancy should be ruled out first in reproductive age women.
  • Goal of evaluation is to differentiate between benign and more serious malignant masses.
  • Increased likelihood of malignancy with:
    • Prepubertal or postmenopausal age
    • Bilaterality, rapid growth, irregularity, and size >10 cm
    • Persistence >12 weeks
    • Complex or solid appearing cyst
    • Presence of ascites
  • Avoid laparoscopic attempt if suspicious for malignancy to prevent risk of rupture and spilling of malignant cells in the pelvis.
  • Transvaginal ultrasound is the standard for evaluation of adnexal masses (2).
  • All prepubertal girls with an adnexal mass should be referred to a specialist with experience in pediatric gynecology.
Copyright © 2016 - 2017
Doctor123.org | Disclaimer